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Introduction: Inﬂammatory biomarkers and scores are important prognostic factors in breast cancer,
and are proposed during the perioperative period. Here, we investigate their correlation and concor-
dance in breast cancer surgical patients. Patients and methods: With the IRB approval and written
informed consent, we included 14 patients (median age: 61 [41 to 82] years) scheduled for conservative
surgery (n ¼ 12) or mastectomy (n ¼ 2) for breast cancer. We measured, at baseline, dayþ1 and dayþ8,
albumin (Alb), C-Reactive Protein (CRP), total white blood cell counts (WBC), lymphocytes (L) and
neutrophils (N) counts, and calculated the following inﬂammatory scores: Neutrophil-to-lymphocyte
ratio (NLR), modiﬁed Glasgow Prognostic Score (mGPS), Prognostic Index (PI) and Prognostic Nutri-
tional Index (PNI). A linear regression model is used to compare CRP and NLR, and the Kappa statistic to
detect discordance (<0) or agreement (>0.4) between the scores. Results: We measured 170 laboratory
values and calculated 182 inﬂammatory scores. CRP, WBC, N and NLR are signiﬁcantly different at dayþ1
compared with baseline (respectively, at baseline, dayþ1 and dayþ8 (median[IQR 25e75]): CRP: 0.1[0.1
e0.6], 0.85[0.2e1.18], 0.18[0.1e0.4]mg/dL; WBC: 6.36[5.91e7.16], 7.45[6.38e8.16], 7.73[6.25e8.54]  103/
mm3; N: 3.78[3.21e4.2], 5.05[4.37e5.99]  103/mm3; and NLR: 1.95[1.67e2.46], 2.62[2.36e3.73], 2.23
[1.46e2.43]) (P < 0.05 for all the comparisons between baseline and dayþ1). Alb and L tend to decrease
(P ¼ 0.06). Discordance is clear between all the inﬂammatory scores (NLR, mGPS, PI, PNI) (Kappa<0).
Conclusion: Inﬂammatory biomarkers and scores, like CRP, WBCs, N, NLR, PNI, and PI are modiﬁed after
a breast cancer surgery, but with discordance and no interchangeability.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Cancer is one of the most important public health problems. For
most solid tumours, surgery is a cornerstone of the curative treat-
ment. In some cases, however, recurrences can be appeared early
[1e3]. Consequently, to identify mechanisms of recurrence and risksiology, St-Luc Hospital, av.
by Elsevier Ltd. All rights reservedfactors that can be monitorised are of prime importance. Inﬂam-
mation seems to be one of the most important perioperative factors
of recurrences, at least in breast, lung and kidney cancers [4].
Various inﬂammatory markers are proposed to be used in cancer
patients, like the C-Reactive Protein (CRP) level, white blood cells
counts (WBC), neutrophil-to-lymphocyte ratio (NLR), platelets-to-
lymphocyte ratio (PLR), the modiﬁed Glasgow prognostic score
(mGPS), Prognostic Index (PI), Prognostic Nutritional Index (PNI)
[5]. As showed by Proctor et al., in their analysis of the Scottish
cancer Registry, mGPS and NLR are seen as the best we can use
routinely as prognostic factors. But whether these data are.
Fig. 1. Linear regression between CRP and Neutrophil-to-lymphocyte ratio in breast
cancer surgical patient.
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is not known whether we should use one, or another, of these
parameters, and/or whether these are interchangeable during the
perioperative period. The interchangeability of these biomarkers
could be challenged by their rapid perioperative time course, as
documented recently for the NLR [4].
In this study, we investigate the correlation and the concordance
between these inﬂammatory scores in breast cancer surgical
patients.
2. Patients and methods
With the approval of the ethics committee of the Catholic Uni-
versity of Louvain, Brussels, Belgium, chaired by Professor J.-M.
Maloteaux) (N/REF2011/30MAI/218, NCT01454856), and after writ-
ten informed consent, we included 14 patients scheduled for breast
cancer surgery under general anesthesia between June to September
2012 inSaint-LucUniversityHospital. Exclusion criteriawere: age less
than 18 or more than 85 years, contraindication to the standardized
anesthetic protocol and inﬂammatory breast cancer disease.
2.1. Patients and procedures
Patients characteristics were: age: 61 [41 to 82] years, weight:
61 [55 to 89] kg (median [range]). Surgery was, in twelve cases,
conservative (quadrantectomy/lumpectomy) and, in two cases, a
mastectomy. Median surgical duration was 79 [60 to 110] min.
Standardized anesthesia was typically induced by 0.1 mcg/kg of
sufentanil, lidocaine 1.5 mg/kg, propofol titrated between 2 and
4 mg/kg and maintained with sevoﬂurane after the insertion of a
laryngeal mask airway. Postoperative analgesia was based on
paracetamol, non-steroidal anti-inﬂammatory drugs after a titra-
tion of intravenous morphine in the post-anesthesia care unit.
Blood samples were taken at baseline, dayþ1 and dayþ8. For
each patient, we measured Albumin (Alb) and CRP, total WBC,
lymphocytes (L) and neutrophils (N) count. All venous blood sam-
ples were processed in a blood analyzer (Sysmex [TOA Medical
Electronics, Kobe, Japan]) for the determination of the leukocytes
counts. The mGPS was calculated on the basis of the CRP  or
>10 mg/L and, in the second case, on the basis of the Alb level < or
35, to obtain a score from 0 to 2. NLR was calculated dividing N by
L, and dichotomized as < or 5. PLR was calculated dividing P by L,
and dichotomized as <150:1, [150:1-300:1] or >300:1). PI was
calculated with a combination between CRP and WBC (CRP < or
>10mg/L andWBC or>11*109). PNI was calculated adding Alb (g/
L) with 5 and multiplied by L (Alb (g/L) þ 5*L*109/L), dichotomized
as < or 45 [5].
2.2. Statistical analysis
Data are presented as mean [range], median [IQR 25e75] and
proportions. ManneWhitney and Fisher's exact tests were used to
compare baseline variables. Wilcoxon matched pairs tests were
used to compare measures at different time. We performed a linear
regression model to compare CRP and NLR. The Kappa statistic was
used to detect discordance (<0) or agreement (>0.4) between each
inﬂammatory scores (concordance analysis). Power analysis, based
on our primary objective (concordance analysis), shows that 11
comparisons are needed to detect discordance (Kappa<0) and 31
for agreement (Kappa > 0.4) with a relative error of 30%. Therefore,
Kappa statistic was performed using the 52 values calculated for
each score [5]. P < 0.05 was considered signiﬁcant. Bonferroni's
correction was used for multiple comparisons. STATISTICA (data
analysis software system, version 7, statsoft Inc. 2004, Tulsa) was
used for all the analyses.3. Results
Wemeasured 170 laboratory values and, additionally, calculated
182 inﬂammatory scores (NLR, mGPS, PI, and PNI). As expected,
CRP, WBC, N and NLR were signiﬁcantly different at dayþ1
compared with baseline. L and Alb showed a tendency toward a
decrease at dayþ1 (Respectively, P ¼ 0.056 and P ¼ 0.059).
Correlation between CRP and NLR was signiﬁcant (P ¼ 0.001)
but moderate with a R2 ¼ 0.275 (Fig. 1).
Concerning inﬂammatory scores, modiﬁcations were seen in
only a minority of the patients, for mGPS, NLR, PI and PNI (Table 1).
One patient had a PI of 2, and another a mGPS of 2 at dayþ1.
Discordance was clear between all the inﬂammatory scores
(NLR, mGPS, PI, PNI) during the perioperative period (Kappa<0 for
all the comparisons).
4. Discussion
Our results conﬁrm that inﬂammatory biomarkers and scores
are modiﬁed (namely, CRP, WBCs, NLR, mGPS, PI, and PNI). How-
ever, these changes appear to be not parallel, and concordance
analyses show clear discordance between the inﬂammatory scores.
Correlation between CRP and NLR was moderate even if signiﬁcant
(R2¼ 0.275, P¼ 0.001). Interchangeability hypothesis can therefore
reasonably be rejected.
The interest of these scores in increasing [4,6,7] during and after
surgery, even if limited data and in the presence of limitations
(small series, monocentric studies, not all type of surgeries), the
usefulness of these scores is suggested as probable [8e11]. But, to
select the best score to be used during the perioperative period,
time course description of their evolution is an important step. If
not one or another would be seen as the best, comparisons between
studies using one or another will not be possible before having
tested their interchangeability. The time course as the lack of
interchangeability is now well documented by our results, in a
relative homogeneous series of breast cancer surgeries, without
biased like different cancer type, stages, surgery or any other
identiﬁed factor inﬂuencing inﬂammatory response.
Nevertheless, limits remain the relative small patients' series
and the monocentric character of our work, even if it seems
improbable that larger, multicentric and even in different cancer
and/or in different surgeries would have given different results.
Table 1
Inﬂammatory biomarkers and scores in 14 patients undergoing surgery for breast cancer. Values are expressed as median [IQR 25e75] or in n/14. (*P < 0.05 for all the
comparisons between baseline and dayþ1; yP ¼ 0.056; zP ¼ 0.059, P > 0.05 for all the other comparisons) (ManneWhitney and Fisher's exact tests to compare baseline
variables, Wilcoxon matched pairs tests to compare measures at different time). Scores presented are: modiﬁed Glasgow prognostic score (mGPS), Prognostic Index (PI), and
Prognostic Nutritional Index (PNI).
Baseline Postoperative dayþ1 Postoperative day þ8
Inﬂammatory biomarkers
C-reactive protein (mg/dL) 0.1 [0.1e0.6] 0.85 [0.2e1.18]* 0.18 [0.1e0.4]
White blood cell count (103/mm3) 6.36 [5.91e7.16] 7.45 [6.38e8.16]* 7.73 [6.25e8.54]
Neutrophils count (103/mm3) 3.78 [3.21e4.2] 5.05 [4.37e5.99]* 4.00 [2.90e5.28]
Lymphocytes count (103/mm3) 1.87 [1.44e2.26] 1.67 [1.34e1.86]y 1.98 [1.84e2.65]
Neutrophil-to-lymphocyte ratio 1.95 [1.67e2.46] 2.62 [2.36e3.73]* 2.23 [1.46e2.43]
Albumin (g/dL) 4.2 [3.8e4.38] 3.8 [3.7e3.9]z 4.25 [3.83e4.5]
Inﬂammatory scores
mGPS > 0 1/14 4/14 2/14
Neutrophil-to-lymphocyte ratio > 5 0/14 1/14 0/14
PI > 0 2/14 4/14 3/14
PNI > 0 2/14 2/14 1/14
P. Forget et al. / International Journal of Surgery 12 (2014) 1360e136213625. Conclusion
Inﬂammatory biomarkers and scores, like CRP, WBCs, NLR, and
PNI are modiﬁed after a breast cancer surgery. But the absence of
concordance between the inﬂammatory scores shows that these
are not interchangeable during the perioperative period and should
not be interpreted as well.
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